Quarterly Report

Taysha Gene Therapies, Inc. Filed 2021-08-16 Acc 0001564590-21-044462

Documents 1

2021-11-10 10-Q Quarterly Report
2021-08-20 4 Chief Financial Officer sold 33,000 shares at an average $16.88 ($557,023)
2021-08-16 10-Q Quarterly Report
2021-08-16 8-K Results of operations · Regulation FD disclosure
2021-05-11 10-Q Quarterly Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading tsha-10q_20210630.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…